$BLD
TopBuild Corp

2024 Q2 Form 10-Q Financial Statement

#000155837024007039 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.366B $1.279B
YoY Change 3.67% 1.07%
Cost Of Revenue $941.7M $891.6M
YoY Change 5.16% -0.39%
Gross Profit $423.9M $387.2M
YoY Change 0.5% 4.57%
Gross Profit Margin 31.04% 30.28%
Selling, General & Admin $213.5M $172.6M
YoY Change 16.3% 1.09%
% of Gross Profit 50.37% 44.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.03M $34.26M
YoY Change 7.62% 6.72%
% of Gross Profit 8.26% 8.85%
Operating Expenses $213.5M $172.6M
YoY Change 16.3% 1.09%
Operating Profit $210.4M $214.5M
YoY Change -11.68% 7.56%
Interest Expense -$18.57M $18.80M
YoY Change 0.05% 4.19%
% of Operating Profit -8.83% 8.76%
Other Income/Expense, Net -$7.218M -$7.513M
YoY Change -256.74% -53.38%
Pretax Income $203.2M $207.0M
YoY Change -8.95% 12.92%
Income Tax $52.45M $54.61M
% Of Pretax Income 25.82% 26.38%
Net Earnings $150.7M $152.4M
YoY Change -8.32% 12.15%
Net Earnings / Revenue 11.04% 11.92%
Basic Earnings Per Share $4.81 $4.82
Diluted Earnings Per Share $4.78 $4.79
COMMON SHARES
Basic Shares Outstanding 31.82M 31.78M
Diluted Shares Outstanding 31.52M 31.84M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $463.2M $968.8M
YoY Change -11.99% 190.26%
Cash & Equivalents $463.2M $968.8M
Short-Term Investments
Other Short-Term Assets $43.55M $29.38M
YoY Change 70.41% 28.5%
Inventory $393.8M $375.1M
Prepaid Expenses
Receivables $859.7M $829.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.760B $2.202B
YoY Change -1.91% 36.56%
LONG-TERM ASSETS
Property, Plant & Equipment $458.6M $467.8M
YoY Change -0.91% -0.79%
Goodwill $2.091B $2.052B
YoY Change 4.96% 7980.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.19M $9.522M
YoY Change -21.06% -42.23%
Total Long-Term Assets $3.143B $3.108B
YoY Change 2.59% 0.64%
TOTAL ASSETS
Total Short-Term Assets $1.760B $2.202B
Total Long-Term Assets $3.143B $3.108B
Total Assets $4.903B $5.310B
YoY Change 0.93% 12.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $461.1M $467.9M
YoY Change -1.59% 3.75%
Accrued Expenses $211.7M $252.7M
YoY Change -6.34% 7.67%
Deferred Revenue $15.98M $15.72M
YoY Change -2.15% -24.22%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $45.67M $46.23M
YoY Change -3.5% 9.11%
Total Short-Term Liabilities $752.2M $784.4M
YoY Change -0.8% 4.41%
LONG-TERM LIABILITIES
Long-Term Debt $1.352B $1.362B
YoY Change -3.38% -3.09%
Other Long-Term Liabilities $1.422M $1.487M
YoY Change -99.31% -71.72%
Total Long-Term Liabilities $1.353B $1.364B
YoY Change -15.77% -3.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $752.2M $784.4M
Total Long-Term Liabilities $1.353B $1.364B
Total Liabilities $2.546B $2.598B
YoY Change -2.83% -1.42%
SHAREHOLDERS EQUITY
Retained Earnings $2.674B $2.523B
YoY Change 30.0% 33.33%
Common Stock $919.7M $912.9M
YoY Change 2.63% 2.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.357B $2.712B
YoY Change
Total Liabilities & Shareholders Equity $4.903B $5.310B
YoY Change 0.93% 12.97%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $150.7M $152.4M
YoY Change -8.32% 12.15%
Depreciation, Depletion And Amortization $35.03M $34.26M
YoY Change 7.62% 6.72%
Cash From Operating Activities $90.35M $178.8M
YoY Change -58.17% 5.29%
INVESTING ACTIVITIES
Capital Expenditures $16.09M $19.88M
YoY Change 6.63% 27.61%
Acquisitions $22.24M
YoY Change -51.49%
Other Investing Activities -$65.34M -$20.63M
YoY Change -29270.09% -54.55%
Cash From Investing Activities -$81.43M -$40.51M
YoY Change 447.71% -33.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $12.06M
YoY Change 23.77%
Cash From Financing Activities -514.9M -17.10M
YoY Change 5673.17% 13.5%
NET CHANGE
Cash From Operating Activities 90.35M 178.8M
Cash From Investing Activities -81.43M -40.51M
Cash From Financing Activities -514.9M -17.10M
Net Change In Cash -505.9M 120.2M
YoY Change -363.22% 28.32%
FREE CASH FLOW
Cash From Operating Activities $90.35M $178.8M
Capital Expenditures $16.09M $19.88M
Free Cash Flow $74.26M $158.9M
YoY Change -63.04% 3.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001633931
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-36870
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
TopBuild Corp
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3096382
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
475 North Williamson Boulevard
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Daytona Beach
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32114
CY2024Q1 dei City Area Code
CityAreaCode
386
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
304-2200
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
BLD
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31817709
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
968809000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
848565000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22398000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23948000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
829221000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
799009000
CY2024Q1 us-gaap Inventory Net
InventoryNet
375056000
CY2023Q4 us-gaap Inventory Net
InventoryNet
364731000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29376000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36939000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2202462000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2049244000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
201392000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
204629000
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
266422000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
264487000
CY2024Q1 us-gaap Goodwill
Goodwill
2052319000
CY2023Q4 us-gaap Goodwill
Goodwill
2042568000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
578335000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
591058000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9522000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10865000
CY2024Q1 us-gaap Assets
Assets
5310452000
CY2023Q4 us-gaap Assets
Assets
5162851000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
467863000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
469585000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
46230000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
47039000
CY2024Q1 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
201402000
CY2023Q4 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
187217000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67041000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65780000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1829000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1917000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
784365000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
771538000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1362498000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1373028000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
243622000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
243930000
CY2024Q1 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
60179000
CY2023Q4 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
58783000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
142552000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
146213000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3716000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4150000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1487000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1554000
CY2024Q1 us-gaap Liabilities
Liabilities
2598419000
CY2023Q4 us-gaap Liabilities
Liabilities
2599196000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39549030
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31818099
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39492037
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31776039
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
395000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
394000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7730931
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7715998
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
705386000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
699327000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
912481000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
906334000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2523300000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2370919000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18757000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14665000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2712033000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2563655000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5310452000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5162851000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1278717000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1265238000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
891567000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
895023000
CY2024Q1 us-gaap Gross Profit
GrossProfit
387150000
CY2023Q1 us-gaap Gross Profit
GrossProfit
370215000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
172642000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
170784000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
214508000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
199431000
CY2024Q1 us-gaap Interest Expense
InterestExpense
18795000
CY2023Q1 us-gaap Interest Expense
InterestExpense
18039000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11282000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1923000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7513000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16116000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
206995000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
183315000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54614000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47445000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
152381000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
135870000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.82
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.31
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.79
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.28
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31641454
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31550658
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31843818
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31713239
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
152381000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
135870000
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4092000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1753000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
148289000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
137623000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
152381000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
135870000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34257000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32100000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5127000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3135000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
561000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-185000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
720000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
720000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4464000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1338000
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
2902000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
1642000
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
240000
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-563000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28486000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10847000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12056000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20096000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7541000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11579000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2659000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-25480000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
16170000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3339000
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-783000
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2239000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
178777000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
169801000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19881000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15580000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
22240000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
45845000
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1608000
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
455000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40513000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60970000
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
12059000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9743000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6059000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6350000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1020000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1029000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17098000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15064000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-922000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-58000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
120244000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93709000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
848565000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240069000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
968809000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333778000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13737000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
18271000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
307000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
835000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1929706000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
135870000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3135000
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
95012
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
2000
CY2023Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
32594
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6350000
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
28840
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1028000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1753000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2065144000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2563655000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
152381000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5127000
CY2024Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
51236
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2024Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
14933
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6059000
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5757
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1020000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4092000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2712033000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1278717000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1265238000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1278717000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1265238000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
392400000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
over the next 18 months
CY2024Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
2804589000
CY2024Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
11177000
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1426000
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
2814340000
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
762021000
CY2024Q1 us-gaap Goodwill
Goodwill
2052319000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
832327000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
827793000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
253992000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
236735000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
578335000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
591058000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17686000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16896000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
13752000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14472000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1408728000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1420067000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
46230000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
47039000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1362498000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1373028000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
34980000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
48750000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
438750000
CY2024Q1 bld Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
900000000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1422480000
CY2024Q1 bld Debt Instrument Covenant Net Leverage Ratio
DebtInstrumentCovenantNetLeverageRatio
3.50
CY2024Q1 bld Debt Instrument Covenant Minimum Interest Coverage Ratio
DebtInstrumentCovenantMinimumInterestCoverageRatio
3.00
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1278717000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1265238000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
214508000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
199431000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7513000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16116000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
206995000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
183315000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.264
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.259
CY2024Q1 bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
2000000.0
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
152381000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
135870000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31641454
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31550658
CY2024Q1 bld Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
95148
CY2023Q1 bld Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
86046
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31843818
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31713239
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.82
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.31
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.79
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.28
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42376
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5127000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3135000
CY2024Q1 bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
2009000
CY2023Q1 bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
45000
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2024Q1 bld Schedule Of Unrecognized Share Based Compensation Expense Nonvested Awards
ScheduleOfUnrecognizedShareBasedCompensationExpenseNonvestedAwards
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;">We have unrecognized share-based compensation expense related to unvested awards as shown in the following table, dollars in thousands:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.78%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of March 31, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:18.62%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrecognized Compensation Expense </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">on Unvested Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:18.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted Average</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Remaining</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Compensation Expense Period</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt 0pt 0pt 12pt;">RSAs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 31,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:9pt;"> 1.2</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt 0pt 0pt 12pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">Total unrecognized compensation expense related to unvested awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 31,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr></table>
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
31455000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3357000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12139000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23270000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24605000
CY2024Q1 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
201402000
CY2023Q4 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
187217000
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
500000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1700000
CY2024Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
11200000
CY2023Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
23100000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53145000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67471000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
46554000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
389000
CY2024Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
31197000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
29920000
CY2024Q1 bld Accrued Sales And Property Taxes Current
AccruedSalesAndPropertyTaxesCurrent
15986000
CY2023Q4 bld Accrued Sales And Property Taxes Current
AccruedSalesAndPropertyTaxesCurrent
17002000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15716000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18365000
CY2024Q1 bld Accrued Customer Rebates Current
AccruedCustomerRebatesCurrent
12177000
CY2023Q4 bld Accrued Customer Rebates Current
AccruedCustomerRebatesCurrent
17326000
CY2024Q1 bld Performance Bonds Outstanding
PerformanceBondsOutstanding
141380000
CY2023Q4 bld Performance Bonds Outstanding
PerformanceBondsOutstanding
145982000
CY2024Q1 bld License And Insurance Related And Other Bonds Outstanding
LicenseAndInsuranceRelatedAndOtherBondsOutstanding
27979000
CY2023Q4 bld License And Insurance Related And Other Bonds Outstanding
LicenseAndInsuranceRelatedAndOtherBondsOutstanding
27415000
CY2024Q1 bld Bonds Outstanding
BondsOutstanding
169359000
CY2023Q4 bld Bonds Outstanding
BondsOutstanding
173397000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-007039-index-headers.html Edgar Link pending
0001558370-24-007039-index.html Edgar Link pending
0001558370-24-007039.txt Edgar Link pending
0001558370-24-007039-xbrl.zip Edgar Link pending
bld-20240331.xsd Edgar Link pending
bld-20240331x10q.htm Edgar Link pending
bld-20240331xex31d1.htm Edgar Link pending
bld-20240331xex31d2.htm Edgar Link pending
bld-20240331xex32d1.htm Edgar Link pending
bld-20240331xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
bld-20240331_cal.xml Edgar Link unprocessable
bld-20240331x10q_htm.xml Edgar Link completed
bld-20240331_def.xml Edgar Link unprocessable
bld-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bld-20240331_pre.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending